HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,929,927 | -6.9% | 1,035,396 | 0.0% | 9.62% | -27.0% |
| Q2 2023 | $36,435,585 | +7.8% | 1,035,396 | 0.0% | 13.19% | -29.6% |
| Q1 2023 | $33,805,679 | -40.7% | 1,035,396 | 0.0% | 18.74% | +5.9% |
| Q4 2022 | $57,050,320 | +14.4% | 1,035,396 | -8.0% | 17.69% | +53.3% |
| Q3 2022 | $49,856,000 | -29.4% | 1,125,673 | -22.3% | 11.54% | -42.7% |
| Q2 2022 | $70,654,000 | -6.0% | 1,448,720 | -6.2% | 20.12% | +20.8% |
| Q1 2022 | $75,139,000 | -35.7% | 1,544,484 | -43.6% | 16.66% | -20.9% |
| Q4 2021 | $116,851,000 | -0.5% | 2,740,411 | -10.5% | 21.05% | +80.0% |
| Q3 2021 | $117,412,000 | +18.7% | 3,063,194 | -12.6% | 11.70% | +0.2% |
| Q2 2021 | $98,936,000 | -14.6% | 3,504,624 | 0.0% | 11.68% | +6.1% |
| Q1 2021 | $115,793,000 | -8.6% | 3,504,624 | 0.0% | 11.00% | -1.6% |
| Q4 2020 | $126,692,000 | +6.6% | 3,504,624 | 0.0% | 11.18% | -38.1% |
| Q3 2020 | $118,807,000 | – | 3,504,624 | – | 18.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |